Drug Report History #873
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v17-EN | Version v4-FR | |
|---|---|---|
| Language (Changed) | Updated to: English | Was: French |
| Date Updated (Changed) | Updated to: 2017-08-02 | Was: 2017-03-13 |
| Drug Identification Number | 02243676 | 02243676 |
| Brand name | RECOMBIVAX HB -(PRESERVATIVE FREE) | RECOMBIVAX HB -(PRESERVATIVE FREE) |
| Common or Proper name | (hepatitis B vaccine [recombinant]) | (hepatitis B vaccine [recombinant]) |
| Company Name | MERCK CANADA INC | MERCK CANADA INC |
| Ingredients | HEPATITIS B SURFACE ANTIGEN | HEPATITIS B SURFACE ANTIGEN |
| Strength(s) | 10MCG | 10MCG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAMUSCULAR | INTRAMUSCULAR |
| Packaging size | 10X1DOSEVIAL | 10X1DOSEVIAL |
| Additional packaging sizes | ||
| ATC code | J07BC | J07BC |
| ATC description | VIRAL VACCINES | VIRAL VACCINES |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-08-01 | 2017-08-01 |
| Actual start date | ||
| Estimated end date | 2018-07-02 | 2018-07-02 |
| Actual end date | ||
| Shortage status (Changed) | Updated to: Actual shortage | Was: Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments (Changed) | Updated to: Limited Quantities available / Quantités limitées disponibles | Was: |
| Health Canada comments |